SciELO - Scientific Electronic Library Online

 
vol.83 número5Un desafío terapéutico: la heterorresistencia en Mycobacterium tuberculosisNódulos peneanos, una rara manifestación clínica de linfogranuloma venéreo índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

  • Não possue artigos citadosCitado por SciELO

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Medicina (Buenos Aires)

versão impressa ISSN 0025-7680versão On-line ISSN 1669-9106

Medicina (B. Aires) vol.83 no.5 Ciudad Autónoma de Buenos Aires dez. 2023

 

CASE SERIES

Hypercalcemic crisis as a presentation of primary hyperparathyroidism

Crisis hipercalcémica como presentación de hiperpara-tiroidismo primario

Iván Bedini1 

Gustavo Sylvestre Begnis1 

Fernando Poenitz2 

David C. Polillo1 

María Cecilia Vargas1 

Diamela Bolzán1 

Luis A. Ramírez Stieben1  * 

1 Unidad de Tiroides y Paratiroides del Grupo Gamma, Rosario, Santa Fe

2 Servicio de Cirugía de Cabeza y Cuello, Sanatorio Británico, Rosario, Santa Fe, Argentina

Abstract

Hyperparathyroidism-induced hypercalcemic crisis (HIHC) is an unusual state of marked progressive pri mary hyperparathyroidism (PHPT). Patients have severe hypercalcemia and may have severe symptoms such as kidney failure, acute pancreatitis, and mental changes. PHPT is due to the presence of a single gland adenoma/ disease in 80 to 85%; parathyroid carcinoma is reported in <1%. Among patients with adenoma, atypical parathy roid tumor can be found infrequently. Parathyroidectomy is the only curative approach for PHPT. In this report we present three cases of HIHC due to giant parathyroid adenomas (GPAs), one of them with histopathological characteristics of an atypical parathyroid tumor, with satisfactory evolution after parathyroidectomy.

Key words: Primary hyperparathyroidism; Hypercal cemic crisis; Parathyroid adenoma; Acute kidney disease

Resumen

La crisis hipercalcémica inducida por hiperparatiroi dismo (HIHC) es un estado inusual de hiperparatiroidis mo primario progresivo y marcado (HPTP). Los pacientes tienen hipercalcemia grave y pueden tener síntomas graves como insuficiencia renal, pancreatitis aguda y cambios mentales. El HPTP se debe a la presencia de un adenoma/enfermedad de una sola glándula en 80 a 85%; el carcinoma de paratiroides se informa en <1%. Entre los pacientes con adenoma, el tumor paratiroideo atípico se puede encontrar con baja frecuencia. La paratiroidec tomía es el único abordaje curativo del HPTP. En este reporte presentamos tres casos de HIHC por adenomas paratiroideos gigantes (APGs), uno de ellos con características histopatológicas de tumor paratiroideo atípico, con evolución satisfactoria luego de paratiroidectomía.

Palabras clave: Hiperparatiroidismo primario; Crisis hipercalcémica; Adenoma paratiroideo; Insuficiencia renal aguda

Hyperparathyroidism-induced hypercalcemic crisis (HIHC) is a rare manifestation of primary hyperparathyroidism (PHPT) occurring in ap proximately 1% of patients1. Patients usually have profound hypercalcemia (serum ≥14 mg/ dl) along with rapid deterioration of central ner vous system, cardiac, gastrointestinal, and renal functions2.

The size of the parathyroid adenoma cor relates with calcium and PTH levels. Although several studies have demonstrated that the av erage elevation in PTH and calcium is significantly higher in parathyroid carcinomas than in benign adenomas, most patients with severe elevations in PTH and calcium still have benign disease1,3,4. We report three cases of PHPT pre senting as HIHC and satisfactory evolution after parathyroidectomy.

Clinical case 1

A 59-year-old man who was admitted due to asthenia, poor general condition, generalized myalgia, hyporexia, decreased diuretic rate, nausea, and vomiting of bilious content for three days. He reported constipation and goat feces associated with a loss of 8 kg of body weight of ap proximately one year of evolution.

During the physical exam the patient was found to have decreased skin turgor, blood pressure of 140/90 mmHg, heart rate of 110 beat per minute, respiratory rate of 20 breath per minute, and an axillary temperature of 36.3°C. The patient was alert and oriented in time, place and person, generalized hyperreflexia, and distal fine tremor were confirmed.

The biochemical reports showed a calcium level of 24.7 mg/dl, a PTH level of 2416 pg/ml, and a serum creatinine level of 2.84 mg/dl. Table 1 (case 1) summarizes the bio chemical findings. Biochemical reports suggested PHPT. Ul trasonography (USG) did not reveal any parathyroid lesions, while parathyroid scan coupled with SPECT using 99mTc-sestamibi tracer showed a 30 mm mass in superior medias tinum, to the right of the esophagus and in contact with the posterior edge of the trachea. Hydration was started with crystalloids and, later, loop diuretics. Due to the persistence of severe hypercalcemia, emergency hemodialysis was per formed. Finally, minimally invasive parathyroidectomy was performed with normalization of calcium levels. Pathology revealed a lesion with a maximum diameter of 25 mm, 4 grams, without signs of malignancy, compatible with a gi ant parathyroid adenoma (GPA).

Tabla 1 Biochemical characteristics of patients before surgery and at discharge 

At the follow-up three year later, a recurrence of hy perparathyroidism was confirmed due to a hyperplasia of two parathyroid glands.

Clinical case 2

A 67-year-old man with a history of arterial hyperten sion, bipolar disorder, and benign prostatic hyperplasia, who was admitted with a two-week history characterized by alteration in his behavior over the past two weeks, in the form of apathy, irritability, and decreased alertness. In treatment with valproic acid, lamotrigine, quetiapine, tera zosin, tamsulosin, and amlodipine. Physical examination: dry mucosa, decreased skin turgor. Blood pressure 100/70 mmHg, heart rate 100 /min, respiratory rate 16 /min. Brad ypsychia, irrelevant talk, without neck stiffness. A 30-mm elastic, a palpable nodule was detected in projection of the right thyroid lobe. Biochemical reports showed a serum calcium level of 14.1 mg/dl, serum phosphate of 2.47 mg/ dl, PTH of 1143 pg/ml, and serum creatinine of 1.73 mg/ dl (Table 1). USG revealed a 25-mm nodular mass behind the upper pole of the left thyroid lobe. Parathyroid scan coupled with SPECT using 99mTc-sestamibi tracer showed a nodular image of approximately 20 mm, suggesting the presence of a left upper parathyroid adenoma. Hydration with crystalloids was started and 48 hours after admis sion parathyroidectomy was performed. Pathology study revealed a parathyroid adenoma of 8 grams, 40 mm by 20 mm, without signs of malignancy, compatible as GPA. Af ter surgery, a normalization of calcium and PTH levels was found. These findings suggested HC due PHPT.

After one year of follow-up, the patient is in remission, with normal levels of serum calcium, serum phosphate, and PTH.

Clinical case 3

A 58-year-old man with a history of hepatic transplant for non-alcoholic steatohepatitis complicated with post-surgical stricture of the bile duct, undergoing hospital ization for acute cholangitis, with percutaneous drain age placement and antimicrobial treatment. The patient evolved with acute confusional state. The biochemical report showed a serum calcium adjusted for albumin of 23.46 mg/dl, PTH of 764 pg/ml, and serum creatinine of 1.94 mg/dl (Table 1, case 3). USG revealed an 18-mm hy poechoic nodular lesion adjacent to the right thyroid lobe. Magnetic resonance imaging (MRI) of the cervical region showed a mass measuring 50 by 18 mm, hypointense on T1 and hyperintense on T2, in low right laterocervical to pography. Hydration was started to reduce pre-surgical serum calcium levels and parathyroidectomy was per formed. Pathology showed a parathyroid adenoma of 7 grams, 40 mm by 30 mm, with extensive hemorrhage, and solid/trabecular growth patterns compatible with an atypical giant adenoma. After surgery, calcium and PTH levels returned to normal range (Table 1).

The publication was approved by the Ethics Commit tee of the Grupo Gamma, and written informed consent was obtained from each participant.

Discussion

HIHC is an unusual state of progressive and marked of PHPT. Patients with HIHC have pro found hypercalcemia (serum calcium ≥14 mg/dl) resulting in anorexia, vomiting, dehydration, de creased renal function, impaired mental status, confusion, coma, and if untreated, death1,2,5. In this report, we present three cases of PHPT that presented with severe hypercalcemia with satis factory evolution after parathyroidectomy.

Patients with HIHC may have severe symp toms such as renal failure, acute pancreatitis, and mental changes5. In our report, the most frequent symptoms were dehydration with renal failure and altered mental status. These symptoms im proved markedly after parenteral hydration and as expected, after parathyroidectomy.

HIHC demands an accelerated approach and requires immediate improvement within hours. Conservative management strategy for HIHC in cludes rapid intravascular volume expansion with isotonic saline solution, and loop diuretics as furo semide to induce calciuresis1-3. Most patients pre senting with severe hypercalcemia have intravas cular volume depletion. This situation exacerbates hypercalcemia by altering renal calcium clearance. Isotonic saline solution for 24 to 48 hours corrects possible volume depletion and consequently low ers calcium levels. In some cases, hemodialysis may be considered6, as in one of our patients. On the other hand, the use of bisphosphonates is controversial and may be associated with an in creased risk of hypocalcemia in the postoperative period7. However, although medical treatment can rapidly reduce serum calcium levels, the definitive approach is urgent parathyroidectomy due to the life-threatening risk to patients.

Ultrasonography (USG) and (99mTc)-sestami bi scintigraphy (with SPECT) are recommended as first-line imaging methods, with the goal of obtaining preoperative localization. If two stu-dies are concordant, the positive predictive val ue for the correct localization of the parathyroid tumor is close to 97%8, and one can go for mini mally invasive or focused parathyroidectomy. This technique has modified the management of hypercalcemic crisis, due to a shorter operat ing time, smaller incision, and less perioperative pain2. Our patients underwent a focused para thyroidectomy, achieving biochemical remission of the disease in the short term and without complications associated with the surgical procedure, such as hematoma/bleeding in the sur gical bed or neuronal damage.

PHPT is due to the presence of an adenoma/ single-gland disease in 80-85%. Although para thyroid carcinoma is a rare cause of PHPT, it can be seen in about 5% cases of HIHC1,4,9. However, the most common pathological finding in HIHC is a solitary parathyroid adenoma. Other types of tumors, such as GPA and atypical parathyroid tumors, are less frequent. Interestingly, our pa tients had GPAs adenomas and one of them had a GPA with characteristics of an atypical para thyroid tumors. None of our patients present ed histopathological findings compatible with parathyroid carcinoma.

GPA is a rare type of parathyroid adenoma defined as weighing >3.5 g, and consequently, only a few cases of GPA have been reported. A systematic review by Wong et al. identified 65 GPAs10. Subsequently, four more cases were pub lished11,12. They manifest as PHPT but exhibit el evated laboratory parameters and severe clinical manifestations5,13, bearing a closer resemblance to parathyroid carcinoma rather than a typical benign adenoma. This should draw attention to the potential malignant nature of the tumor14.

Furthermore, histopathological analysis of parathyroid tumors of HIHC may display some unique features which include necrosis, fibrosis, extensive hemorrhage, microcystic pattern, and presence of intracytoplasmic vacuoles9. Some reports have suggested that hemorrhage with in an intact parathyroid gland may precipitate HIHC. Only one of our patients (case 3) showed evidence of intratumoral hemorrhage in the pa thology.

In 2022, the WHO reclassified atypical para thyroid adenomas now as atypical parathyroid tumors due to their potential for malignant be havior15. These tumors display some histologic features that can often be seen in parathyroid car cinoma, such as cytologic atypia, sheet-like or tra becular growth, adherence to adjacent structures, fibrosis (which may be band-like, tumor cells ex tend towards the tumor capsule but not through it) and mitotic activity, but do not present other signs such as full-thickness capsular invasion, vascular invasion, perineural invasion or invasion of adjacent structures15. One of our patients (case 3) presented a GPA with a solid trabecular growth pattern. In these situations, parafibromin immunohistochemistry is recommended to appreciate the risk of recurrence and to estimate de possibil ity of an underlying CDC73 mutation15. However, we do not have this immunohistochemistry panel to estimate these issues. To date, the patient has not presented signs of recurrence.

Hungry bone syndrome is a rapid, severe, and prolonged hypocalcemia following parathyroid ectomy, caused by an abrupt drop in PTH levels and osteoclastic resorption. Risk factors include a PTH level >1000 pg/ml, and alkaline phospha tase levels three times higher than the normal upper limit13. Although our patients had low calcium levels during follow-up, they did not present this syndrome, possibly due to routine administration of calcitriol and calcium after surgery.

References

1. Gurrado A, Piccinni G, Lissidini G, Di Fronzo P, Vittore F, Testini M. Hypercalcaemic crisis due to primary hyperparathyroidism - a systematic literature review and case report. Endokrynol Pol 2012; 63: 494-502. [ Links ]

2. Lew JI, Solorzano CC, Irvin GL 3rd. Long-term re sults of parathyroidectomy for hypercalcemic crisis. Arch Surg 2006; 141: 696-9. [ Links ]

3. Sala TD, Mureşan S, Roman R, Lazăr A, Ion R, Paşcanu I. Hypercalcaemic crisis due to primary hyperparathyroidism: report of two cases. J Crit Care Med (Targu Mures) 2019; 5: 34-9. [ Links ]

4. van Wynne , AG HJCJF la. Parathyroid carcinoma: clinical and pathologic features in 43 patients. Medi cine 1992; 71: 197-205. [ Links ]

5. Singh DN, Gupta SK, Kumari N, et al. Primary hyper parathyroidism presenting as hypercalcemic crisis: Twenty-year experience. Indian J Endocrinol Metab 2015; 19: 100-5 [ Links ]

6. Bentata Y, El Maghraoui H, Benabdelhak M, Haddiya I. Management of hypercalcaemic crisis in adults: Current role of renal replacement therapy. Am J Emerg Med 2018; 36: 1053-6. [ Links ]

7. Phitayakorn R, McHenry CR. Hyperparathyroid cri sis: use of bisphosphonates as a bridge to parathy roidectomy. J Am Coll Surg 2008; 206: 1106-15. [ Links ]

8. Khan AA, Hanley DA, Rizzoli R, et al. Primary hy perparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Ca nadian and international consensus. Osteoporos Int 2017; 28: 1-19. [ Links ]

9. Starker LF, Björklund P, Theoharis C, Long WD 3rd, Carling T, Udelsman R. Clinical and histopatho logical characteristics of hyperparathyroidism-induced hypercalcemic crisis. World J Surg 2011; 35: 331-5. [ Links ]

10. Wong HKG, Shipman K, Allan K, Ghabbour A, Borumandi F. Giant parathyroid tumours in primary hyperparathyroidism: a systematic review. Langenbecks Arch Surg 2022; 407: 501-16. [ Links ]

11. Gossili F, Carlé A, Andersen TB, Zacho HD. Giant Para thyroid Tumor: Parathyroid Adenoma versus Parathy roid Carcinoma. Case Rep Endocrinol 2022; 2022: 7712097. [ Links ]

12. Bhan A, Athimulam S, Kumari P, et al. Large para thyroid adenomas: Potential mechanisms to rec oncile adenoma size and disease phenotype. Front Endocrinol (Lausanne) 2023; 14: 1009516. [ Links ]

13. Shah S, Fujikawa P, Brand K, Munshi V, Patel K. Giant parathyroid adenoma: a case report. Cureus 2023; 15: e34140. [ Links ]

14. Cetani F, Marcocci C, Torregrossa L, Pardi E. Atypical parathyroid adenomas: challenging lesions in the differential diagnosis of endocrine tumors. Endocr Relat Cancer 2019; 26: R441‐64. [ Links ]

15. Erickson LA, Mete O, Juhlin CC, Perren A, Gill AJ. Overview of the 2022 WHO Classification of Para thyroid Tumors. Endocr Pathol 2022; 33: 64-89. [ Links ]

Recibido: 28 de Marzo de 2023; Aprobado: 15 de Septiembre de 2023

*Postal address: Luis A. Ramírez Stieben, Pte. Roca 2440, 2000 Rosario, Santa Fe, Argentina E-mail: lramirez@grupogamma.com

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License